Best Life Sciences Companies in Memphis, United States
The 51 best Life Sciences companies in Memphis, United States in 2026, ranked by funding and momentum. Funding, investors, founders, valuation, tech stack and live signals. Top: Triad Life Sciences.
Our analysis of 164 Life Sciences companies
$34.7b in tracked funding; 83% of the stack-profiled cohort runs cloud-native; funding activity peaked in 2025.
Ranked: Best Life Sciences companies in Memphis
| # | Company | Disclosed funding | Last round | Stage | Employees | Founder | Tech stack | Patents & IP focus | Recent signals |
|---|---|---|---|---|---|---|---|---|---|
| 1 | Triad Life Sciences Developer of regenerative medicine technologies | $32M | 59 mo ago | Acquired | 33 | — | — | — | — |
| 2 | Transnetyx Developer of automated-genotyping services for murine cell lines | $22M | 99 mo ago | Acquired | 150 150 → 140 (-7%) | — | StoryblokSentryNode.js+24 | 31 patents High-throughput genetic and forensic DNA screening with real-time sequence detection | — |
| 3 | SweetBio Developer of wound-healing therapies for oral surgery | $17M | 43 mo ago | Series B | 7 | Kayla Rodriguez Co-Founder & CEO | Cart FunctionalitySquarespace CommerceSquarespace+14 | 2 patents Biomaterial compositions for bone and soft tissue regeneration therapies | 2 partnerships |
| 4 | NovaLign Orthopaedics Orthopaedic implants for long bone fractures | $10M | 228 mo ago | Acquired | — | Jeff Roberts CEO & President | — | 15 patents Modular intramedullary fixation systems for long‑bone fracture stabilization and alignment | — |
| 5 | In2Bones USA Global surgical device and equipment manufacturer focused on improving patient outcomes | $10M | 87 mo ago | Acquired | — | — | — | 211 patents Orthopedic fixation hardware: bone plates, screws, staples, and related surgical implant systems. | — |
| 6 | iScreen Vision Pediatric vision screening equipment and analysis | $7M | 141 mo ago | Series B | 16 | Buck Brown President & CEO | WordPressMySQLPHP+13 | — | — |
| 7 | Ariste Medical Drug eluting surgical implants to prevent device failure | $7M | 64 mo ago | Series A | 6 | — | — | — | — |
| 8 | Hapten Sciences Biopharmaceutical research company developing novel products for global health | $6M | 81 mo ago | Seed | — | Raymond Hage Founder & CEO | — | — | — |
| 9 | Cross Roads Extremity Orthopaedic devices for complex foot & ankle problems | $5M | 60 mo ago | Acquired | 20 | Chad Hollis Co-Founder | WordPressMySQLPHP+18 | — | — |
| 10 | Hypermed Hyperspectral imaging for tissue oximetry, advancing healthcare with innovative technology | $5M | 100 mo ago | Series A | 7 | — | — | 27 patents Hyperspectral/multispectral medical imaging for tissue oxygenation and diabetic foot diagnostics | — |
| 11 | ExtraOrtho Orthopedic external fixation system | $4M | 181 mo ago | Acquired | — | Brian Austin President & CEO | — | 41 patents Advanced locking and articulation mechanisms for orthopedic external fixation clamps | — |
| 12 | Cagenix Titanium dental frameworks | $3M | 180 mo ago | Series A | 26 | Carl Schulter Founder | — | 33 patents Design and manufacturing of dental implant frameworks and prosthetic overdenture systems. | — |
| 13 | Immuno Technologies Preclinical research for vaccines and diagnostic assays against infectious diseases | $3M | 167 mo ago | Funding Raised | — | — | — | — | — |
| 14 | Quire Data AI solutions for healthcare and beyond, enhancing efficiency and growth | $3M | 151 mo ago | Seed | 8 | — | — | — | — |
| 15 | Silicone Arts Laboratories Replica of human eye and Scar filler to fill skin defects | $3M | 136 mo ago | Series A | 5 | — | — | — | — |
| 16 | Health & Bliss Developer of technology-based diagnostic-test for infectious disease | $2M | 154 mo ago | Deadpooled | — | Bliss Lansing Founder | — | — | — |
| 17 | Tavo Biotherapeutics Developer of therapeutics to treat ophthalmic diseases to preserve and enhance vision through injectionless… | $1M | 23 mo ago | Funding Raised | — | Monica Jablonski Founder | — | — | — |
| 18 | US Biologic Innovative oral vaccine technology company focused on global disease prevention | $1M | 105 mo ago | Funding Raised | 10 | — | — | 32 patents Oral biologic delivery systems and antimicrobial peptide vaccines for animal disease control | — |
| 19 | Test Anywhere Technology Provider of infectious disease testing devices | $750K | 118 mo ago | Deadpooled | — | Chase Lansing Co-Founder | — | — | — |
| 20 | Urova Medical Device to treat Stress incontinence in women | $405K | 151 mo ago | Deadpooled | 1 | Frank Yao Founder | — | — | — |
| 21 | Mobilizer Solves the problem of ambulation | $350K | 150 mo ago | Seed | — | James Bell Co-Founder & CEO | — | — | — |
| 22 | Grace Medical ENT solutions innovator: ossicular & stapes prostheses, instruments, and surgical systems | $158K | 183 mo ago | Acquired | 78 | — | Cart FunctionalityMicrosoft ASP.NETAzure+8 | — | 2 launchs |
| 23 | Diatech Diabetes Providing a software platform for monitoring insulin delivery | $150K | 24 mo ago | Seed | 6 | Luis Blanco Co-Founder & Chief Technology Officer | — | 6 patents Detecting and monitoring disruptions in medical fluid delivery infusion devices | — |
| 24 | EndoInSight Endometriosis education, activism, and awareness resource platform | $150K | 141 mo ago | Seed | 6 | Byron Smith Co-Founder | — | — | — |
| 25 | BioNanovations Handheld bacterial diagnostic using nanoparticles | $140K | 154 mo ago | Seed | 2 | Charleson Bell President and co-Founder | — | — | — |
Top 12 Life Sciences companies in Memphis
#1
Funding Raised · Memphis, Tennessee · founded 2024$1.3Mraised▾
Developer of therapeutics to treat ophthalmic diseases to preserve and enhance vision through injectionless therapies. It offers topical microemulsion technology that preserves and enhances sight for the treatment of vision loss, AMD, inherited retinal dystrophies, and glaucoma.
- Sep 2024Grant (prize money)$1.1M
- Jun 2024Grant (prize money)$280K
#2
Series B · Memphis, Tennessee · founded 2015 · 7 employees$17.2Mraised▾
Developer of wound-healing therapies for oral surgery. It offers VERIS for Acute Wound for skin cancer surgery, Orthopedics, and APIS for Chronic Wounds used for diabetic ulcers wound dressing.
- Dec 2022Series B$8.1M
- Oct 2020Series A$2.8M
- Sep 2019Series A$803.6K
- Oct 2018Series A$3.1M
#3
Acquired · Memphis, Tennessee · founded 2017 · 33 employees$32.2Mraised▾
Developer of regenerative medicine technologies. The company has developed an InnovaMatrix AC regenerative technology platform that uses mammalian extracellular matrices for treating various diseases especially focused on wound care, orthopedics, surgical care, ophthalmic care, and skincare.
- Aug 2021Series B$18.3M
- Apr 2020Series A$6.6M
- May 2019Series A$3.3M
- Mar 2019Series A$3M
#4
Seed · Memphis, Tennessee · founded 2019 · 6 employees$150Kraised▾
Providing a software platform for monitoring insulin delivery. Its technology enables insulting pumps to detect different types of infusion failures not currently detected by other insulin pumps like leaks, kinks/ partial occlusions, infusion into damaged sites, and dislodgements.
- Jul 2024Conventional Debt$100K
- Dec 2021Seed$150K
- Sep 2021Grant (prize money)$300K
- Jun 2021Seed$25K
#5
Series A · Memphis, Tennessee · founded 2007 · 6 employees$6.5Mraised▾
Ariste is a preclinical stage company that develops drug eluting surgical implants to prevent common causes of device failure. It has developed a unique, patented formula that enables the application and elution of drugs from devices made from PTFE that significantly reduces common device complications due to restenosis, thrombosis, and infection. It has two US patents. The company is currently developing a drug-eluting hernia mesh.
- Mar 2021Series A$56.1K
- Aug 2018Series A$50K
- Aug 2018Conventional Debt—
- Sep 2017Series A$300K
#6
Acquired · Memphis, Tennessee · founded 2014 · 20 employees$5.4Mraised▾
CrossRoads Extremity designs products for surgeons treating patients with complex foot and ankle problems. Its products include CrossTIE, a pre-assembled sterile packed PIP arthrodesis instrument, and implant; MotoCLIP, an elastic Nitinol fixation, and insertion system; Allograft, pre-shaped wedges; moldable DBM putty fixation; and precision titanium headed, headless, and snap-off screws for secure fixation.
- Jul 2021Venture Debt$15M
- Jan 2018Series A$3M
- Jun 2016Seed$411K
- Jun 2015Seed$1.8M
#7
Seed · Memphis, Tennessee · founded 2010$6.5Mraised▾
Biopharmaceutical research company developing novel products for global health. This privately held company focuses on identifying and efficiently developing novel, early-stage biopharmaceutical products. The aim is to significantly contribute to the health and well-being of people around the world through innovative research and development. The company operates in the biopharmaceutical industry, focusing on early-stage product development. They offer subscription services for company updates. Their business model involves research, product development, and potentially licensing or partnering to bring products to market.
- Oct 2019Seed$886K
- Sep 2018Seed$1.6M
- Feb 2017Seed$1.2M
- Jan 2016Seed$1.2M
#8
Acquired · Memphis, Tennessee · founded 2000 · 150 employees$22.5Mraised▾
Developer of automated-genotyping services for murine cell lines. Researchers can clip their samples in the custom Transnetyx well plate and place an order online. Once the sample is received, the company will use its custom automated system to provide genotyping results.
- May 2018Conventional Debt$22.5M
- Apr 2015Conventional Debt—
#9
Acquired · Memphis, Tennessee · founded 2014$9.6Mraised▾
Global surgical device and equipment manufacturer focused on improving patient outcomes. The company develops, manufactures, and sells a broad range of surgical equipment and medical devices. Their offerings span across orthopedics, sports medicine, gastroenterology, general surgery, and patient care. They provide surgical instruments, electrosurgical units, insufflation systems, smoke evacuation solutions, and medical imaging technologies. The company also offers medical education resources, including blogs, clinical insights, and training programs for healthcare professionals. They are committed to innovation and supporting healthcare partners in delivering exceptional patient care worldwide. Their products are designed to enhance surgical procedures and improve patient recovery.
- May 2019Series A$3.6M
- Jun 2017Series A$1.5M
- Mar 2017Series A$3.5M
- Oct 2015Seed$1M
#10
Series B · Memphis, Tennessee · founded 2009 · 16 employees$7.5Mraised▾
iScreen Vision is a medical device company offering vision screening devices and analysis to the pediatric market. Using its patented technology for digital photoscreening for pediatric vision problems, including refractive errors such as myopia, hyperopia, astigmatism and anisometropia; eye alignment problems, such as strabismus; anisocoria, ptosis; and media opacities such as cataracts. According to the company, digital photoscreening doesn't require a patient response, hence, useful for vision screening of non-verbal, non-compliant, and developmentally challenged children.
- Oct 2014Series B$187.6K
- Sep 2013Series B$4M
- Mar 2011Series A$3.3M
#11
Acquired · Memphis, Tennessee · founded 2005$10Mraised▾
NovaLign Orthopaedics(known as OsteoLign till 2009) develops minimally invasive products for treating long bone fractures like those of bones in the thigh, shin, and calf. It makes Intramedullary fixation system, an FDA cleared system of implants and instruments for humerus, tibia, and femoral fractures that allow less invasive fixation without affecting surrounding joints; and Extra-capsular intramedullary device that allows a surgeon to repair a long bone fracture. Novalign was acquired by Sonoma Orthopaedics in 2011
- Jul 2007Series B$10M
#12
Series A · Memphis, Tennessee · founded 2012 · 7 employees$5Mraised▾
Hyperspectral imaging for tissue oximetry, advancing healthcare with innovative technology. They are pioneers in medical hyperspectral imaging, specializing in surface tissue oximetry solutions. Their technology assesses oxyhemoglobin, deoxyhemoglobin, and oxygen saturation in superficial tissue, crucial biomarkers for tissue health. This helps clinicians understand the vascular system's ability to support tissue viability. Their solutions address the need for quick and efficient determination of surface tissue oxygenation, aiding in preventing complications like non-healing wounds. They offer advanced portable imaging solutions, setting a new standard of care with patented technology. Their product, cleared by regulatory bodies, delivers diagnostic information in a portable configuration. They focus on innovation in medical imaging, impacting healthcare through advanced diagnostic capabilities.
- Mar 2018Series A$5M
Funding & investor landscape
Notable founders
Market landscape — 10 sub-themes by coverage
Share of Life Sciences coverage by sub-theme.
Regulatory-risk over time rising
Funding & growth over time
funding rising · growth rising
How research on Biotechnology is moving in the United States
A read on the academic research around Biotechnology — which themes are gaining ground, the institutions and researchers driving them, and how the tone is shifting. Based on 6,260 United States-affiliated papers.
- Harvard University209
- Cornell University177
- University of Tennessee at Chattanooga140
- Howard Hughes Medical Institute126
- Johns Hopkins University121
- Gene33→164
- Transcription (linguistics)11→79
- Antibody11→62
- Genome6→56
- Mutation7→56
- Gene8→110
- Cell culture3→62
- Gene expression3→62
- Fermentation2→54
- Downregulation and upregulation1→50
- Agriculture19→58
- Antibiotic resistance15→45
- Public health4→31
- Gene6→30
- Production (economics)5→29
Where biotechnology is researched across United States
Location clusters by institution affiliation — each city's volume, stance tone, and a quick read on its hot topic, what's advancing, the opening opportunity, and the main concern.
Who's filing biotechnology patents in the United States
United States biotechnology patent filing is accelerating — 457,918 filings from 8,000 assignees (2016–2025), led by Genentech, UNIV California, Regeneron Pharma; annual filings 36884→44446.
- Genentech18078
- UNIV California17948
- Regeneron Pharma16082
- Amgen10495
- Monsanto Technology9742
- UNIV Pennsylvania8521
- Harvard College7460
- UNIV Texas7378
Common questions
Rohit lives in the feed. He covers what's moving right now — the funding rounds, launches and shifts breaking across the trade press — and ties them back to where the sector is heading.